A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis
Clinical trial NCT06718101 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06718101
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-19
- Primary completion
- 2027-05-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.